Received this from RedChip this morning: Learn
Post# of 148183
(Total Views: 529)
Posted On: 02/19/2020 9:20:40 AM
Received this from RedChip this morning:
Learn About This Late Stage Biotechnology Company Developing Innovative Treatments: CytoDyn (OTCQB: CYDY)
Join the Investor Group Call on Thursday, February 20th at 4 PM ET
Dr. Nader Pourhassan, Director, President & CEO of CytoDyn Inc. (OTCQB: CYDY), a late stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor, will host an investor group call Thursday, February 20, 2020 at 4 pm Eastern/1 pm Pacific.
To join the free call, which will not be archived, at 4 pm Eastern please dial 866-821-0302. There is no passcode. If you have any questions, please reach RedChip Specialist Craig Brelsford at (407) 571-0902, or reply to this email. Note to callers outside the United States: Please reach Craig Brelsford for the dial-in number for your country.
Learn About This Late Stage Biotechnology Company Developing Innovative Treatments: CytoDyn (OTCQB: CYDY)
Join the Investor Group Call on Thursday, February 20th at 4 PM ET
Dr. Nader Pourhassan, Director, President & CEO of CytoDyn Inc. (OTCQB: CYDY), a late stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor, will host an investor group call Thursday, February 20, 2020 at 4 pm Eastern/1 pm Pacific.
To join the free call, which will not be archived, at 4 pm Eastern please dial 866-821-0302. There is no passcode. If you have any questions, please reach RedChip Specialist Craig Brelsford at (407) 571-0902, or reply to this email. Note to callers outside the United States: Please reach Craig Brelsford for the dial-in number for your country.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼